Savara Pharmaceuticals
Advertisement
Savara Pharmaceuticals is a clinical-stage biopharmaceutical company based in Austin, TX, specializing in rare respiratory diseases. Their lead product candidate, MOLBREEVI, is currently in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP), focusing on providing improved treatment options for affected individuals.
The company is dedicated to advancing scientific research and clinical trials related to aPAP, and actively engages with investors, patients, and healthcare professionals through various resources and events. Savara's commitment to innovation underscores their mission to enhance the quality of life for those living with rare respiratory conditions.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.
Advertisement



